Author

O. X. Wen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. T. L. Keng· 1 shared E. Tantoso· 1 shared H. Yang· 1 shared J. B.-Y. So· 1 shared L. Chen· 1 shared L. M. Hui· 1 shared M. C. H. Ng· 1 shared O. An· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. T. L. Keng

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

"3G" Trial: An RNA Editing Signature for Guiding Gastric Cancer Chemotherapy

O. An, Y. Song, X. Ke, J. B.-Y. So, R. Sundar, H. Yang, S. Y. Rha, L. M. Hui, T. S. Ting, O. X. Wen, A. T. L. Keng, M. C. H. Ng, E. Tantoso, L. Chen, P. Tan, , Singapore Gastric Cancer Consortium (SGCC)

The paper develops an RNA editing signature (GCRE) to predict chemotherapy response in gastric cancer, achieving 84% accuracy and showing better outcomes in patients with higher editing levels.

bioRxiv · Jun 22, 2020Cancer Biology